Breakthrough drugs generally attract investors’ attention in the pharmaceutical industry although generics make up bulk of the sales in most geographics. Average life expectancy is rising, thanks to the wonders of modern pharmacology, and pushing consumers toward generic versions of expensive brands for cost reasons. While exchange traded funds tracking the broader healthcare sector have become increasingly refined, nobody really …
Category Archive
Below you'll find a list of all posts that have been categorized as “Pharmaceutical ETFs”